Snowball logo
logo
RPRX

Royalty Pharma plc

RPRX โ€ข NASDAQ
$56.31+$0.64ย  (1.15%)

Frequently asked questions

What sector does Royalty Pharma plc (RPRX) operate in?

Royalty Pharma plc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Royalty Pharma plc (RPRX) current stock price?

As of the latest data, Royalty Pharma plc stock price is $56.31, with a previous close of $55.67. Royalty Pharma plc gained $0.64 in the last trading session, representing a 1.15% increase.

What is Royalty Pharma plc (RPRX) current market capitalization?

Royalty Pharma plc market cap is approximately 24.96 billion.

What is Royalty Pharma plc (RPRX) Earnings Per Share (EPS)?

The trailing EPS is $1.90, and the forward EPS is $5.61.

What is Royalty Pharma plc (RPRX) Price-to-Earnings (P/E) ratio?

Royalty Pharma plc current P/E ratio is 29.64, with a forward P/E of 10.03.

What is Royalty Pharma plc (RPRX) EBITDA?

Royalty Pharma plc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 563.15 million.

Does Royalty Pharma plc (RPRX) pay dividends?

Yes. Royalty Pharma plc pays quarterly dividends with an annualized yield of 1.67% and an estimated annual payout of $0.94 per share.

When is the next ex-dividend date for Royalty Pharma plc (RPRX)?

The next ex-dividend date is scheduled for August 15, 2026.

How did Royalty Pharma plc (RPRX) perform in its most recent earnings report?

In the last report (March 31, 2026), Royalty Pharma plc posted an EPS surprise of 10.17% and a revenue surprise of -27.86%.

When is Royalty Pharma plc (RPRX) next earnings report?

Royalty Pharma plc is expected to release its next earnings report on June 30, 2026.

What is Royalty Pharma plc (RPRX) beta (volatility) score?

Royalty Pharma plc has a beta of 0.422, indicating lower volatility than the overall market.